Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,992
Sort by:
Clinical Trials Market Forecast to 2028 - Global Analysis by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)
US$ 4,550.00
The clinical trials market size is expected to reach US$ 25,476.86 million by 2028 from US$ 17,343.46 million in 2022; it is estimated to record a CAGR of 6.8% from 2023 to 2028. Flourishing Pharmace...
July 2023
198 pages
Europe Neurotoxins Market Forecast to 2028 -Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
US$ 3,000.00
The Europe neurotoxins market is expected to grow from US$ 1,174.94 million in 2023 to US$ 2,038.94 million by 2028. It is estimated to register a CAGR of 11.7% from 2022 to 2028. Surge in Cosmetic P...
July 2023
119 pages
Global Cancer Biologics Market Size study & Forecast, by Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, and Immune Checkpoint Inhibitors), by Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030
US$ 3,218.00
Global Cancer Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Cancer biolo...
July 2023
200 pages
Global Hereditary Angioedema Therapeutic Market Size study & Forecast, by Drug Class (C1-esterase inhibitor, Bradykinin B2 receptor antagonist, Kallikrein inhibitor, Others), By Treatment Type (Prophylaxis, On-demand), By Route of Administration (Intravenous, Subcutaneous, Oral) and Regional Analysis, 2023-2030
US$ 4,950.00
Global Hereditary Angioedema Therapeutic Market is valued at approximately USD 4.42 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 202...
July 2023
200 pages
Global Uterine Fibroid Treatment Drugs Market Size study & Forecast, By Drug Class (Gonadotropin-releasing Hormone (GnRH) Agonists, Gonadotropin-releasing Hormone (GnRH) Antagonists, Progestin-releasing Intrauterine Device (IUD) & Contraceptives, Non-hormonal Medications, Others), By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By End-user (Hospital Pharmacies, Retail Pharmacies, other) and Regional Analysis, 2023-2030
US$ 3,218.00
Global Uterine Fibroid Treatment Drugs Market is valued at approximately USD 1.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2023...
July 2023
200 pages
Asia Pacific Neurotoxins Market Forecast to 2028 -Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
US$ 3,000.00
The Asia Pacific neurotoxins market is expected to grow from US$ 925.29 million in 2023 to US$ 1,858.41 million by 2028. It is estimated to register a CAGR of 15.0% from 2023 to 2028. Surge in Cosmet...
June 2023
110 pages
Global Pharmacy Management System Market 2023
US$ 2,250.00
A pharmacy management system (PMS), also known as a pharmacy information system, is a software system that stores data and enables functionality to organize and maintain the medication use process wit...
June 2023
90 pages
Global Pharmaceutical Glass Packaging Market 2023
US$ 2,750.00
Pharmaceutical glass packaging refers to the use of glass containers and vials for the packaging of pharmaceutical products. Glass is a preferred material for pharmaceutical packaging due to its inert...
June 2023
91 pages
Global Pharmaceutical Logistics Market 2023
US$ 3,350.00
Pharmaceutical logistics encompasses the comprehensive management of multiple pharmaceutical products, encompassing medications, healthcare items, medical devices, and raw materials. This intricate pr...
June 2023
92 pages
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), Region - Global Forecast to 2028
US$ 4,950.00
... of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases. The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014 ...
June 2023
150 pages
Global Pharmaceutical Packaging Market 2023
US$ 2,850.00
Pharmaceutical packaging plays a crucial role in ensuring the protection, integrity, and safe delivery of pharmaceutical products to patients. It encompasses a comprehensive process that involves the...
June 2023
89 pages
Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 4,550.00
The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028. Th...
June 2023
720 pages
Middle East & Africa CIN & HR-HPV Treatment Market Forecast to 2028 –Regional Analysis – by Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 3,000.00
The Middle East & Africa CIN & HR-HPV treatment market is expected to grow from US$ 534.50 million in 2023 to US$ 742.37 million by 2028. It is estimated to grow at a CAGR of 6.8% from 2023 to 2028. D...
June 2023
101 pages
Asia Pacific CIN & HR-HPV Treatment Market Forecast to 2028 –Regional Analysis – by Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 3,000.00
The Asia Pacific CIN & HR-HPV treatment market is expected to grow from US$ 2,738.94 million in 2023 to US$ 3,949.99 million by 2028. It is estimated to grow at a CAGR of 7.6% from 2023 to 2028. Use...
June 2023
115 pages
Brazil Vitamin K2 Market Forecast to 2028 - COVID-19 Impact and Country Analysis by Product (MK-4, MK-7, and Combination Drugs), Dosage Forms (Capsules & Tablets, Powder, and Oils), Source (Natural and Synthetic), and Application (Pharmaceuticals, Nutraceuticals and Food, and Others)
US$ 3,000.00
The Brazil vitamin K2 market is projected to reach US$ 9.81 million by 2028 from US$ 1.59 million in 2022; it is estimated to grow at a CAGR of 35.6% from 2023 to 2028. The growth of the Brazil vitami...
June 2023
109 pages
Europe CIN & HR-HPV Treatment Market Forecast to 2028 –Regional Analysis – by Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 3,000.00
The Europe CIN & HR-HPV treatment market is expected to grow from US$ 3,771.58 million in 2023 to US$ 5,119.63 million by 2028. It is estimated to grow at a CAGR of 6.3% from 2023 to 2028. Increase i...
June 2023
117 pages
North America CIN & HR-HPV Treatment Market Forecast to 2028 –Regional Analysis – by Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 3,000.00
The North America CIN & HR-HPV treatment market is expected to grow from US$ 4,872.99 million in 2023 to US$ 6,693.51 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2023 to 2028. Fav...
June 2023
109 pages
South America CIN & HR-HPV Treatment Market Forecast to 2028 –Regional Analysis – by Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 3,000.00
The South America CIN & HR-HPV treatment market is expected to grow from US$ 490.90 million in 2023 to US$ 659.12 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2023 to 2028. Favorab...
June 2023
97 pages
Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 4,550.00
The transdermal medical patch market is expected to grow from US$ 8.24 billion in 2022 to US$ 10.79 billion by 2028; it is estimated to register a CAGR of 4.0% from 2023 to 2028. Major factors drivin...
June 2023
194 pages
Natural Source Vitamin E (Tocopherols and Tocotrienols) – A Global Market Overview
US$ 4,500.00
... 8.5 thousand metric tons in 2018. Research Findings & Coverage Global Natural Source Vitamin E market is analyzed in this report with respect to key ... the following key product types of Natural Vitamin E: Tocopherols Tocotrienols End-Use sectors of Natural Vitamin E analyzed comprise the following: Animal ...
June 2023
235 pages
Asia and Africa Lateral Flow Assay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Kits & Reagents and Lateral Flow Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing), Technology (Sandwich Assay, Competitive Assays, and Multiplex Detection Assay), and End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Diagnostics Laboratories, Homecare, Veterinary Clinics, and Others)
US$ 3,000.00
The Asia and Africa lateral flow assay market size was valued at US$ 1.50 billion in 2022 and is projected to reach US$ 2.15 billion by 2028; it is estimated to grow at a CAGR 6.6% during 2023–2028. T...
May 2023
297 pages
Clinical Trial Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
US$ 4,550.00
The clinical trial imaging market size is expected to reach US$ 2.48 billion by 2028 from US$ 1.61 billion in 2022; it is estimated to record a CAGR of 7.6% from 2023 to 2028. Spur in Number of CROs O...
May 2023
186 pages
Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)
US$ 4,550.00
The drug delivery market size is expected to grow from US$ 2,099.85 billion in 2022 to US$ 3,254.59 billion by 2028; it is estimated to record a CAGR of 7.7% from 2023 to 2028. The drug delivery mark...
May 2023
314 pages
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
US$ 3,218.00
Global Acute Myeloid Leukemia Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute...
May 2023
200 pages
Global Advanced Drug Delivery Systems Market Size study & Forecast, by Type ( Oral Drug Delivery System, Injection-based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Trans mucosal Drug Delivery System, Carrier-based Drug Delivery System and Other Types) by Application ( Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System, Ophthalmology and Others), by Technology ( Prodrug, Implants and Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery and Other Technologies) and Regional Analysis, 2023-2030
US$ 3,218.00
Global Advanced Drug Delivery Systems Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-203...
May 2023
200 pages
Global CAR T-Cell therapy Market Size study & Forecast, by Indication (Lymphoma, Acute Lymphocytic Leukemia, Others), By Drug Type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others), By End user (Hospitals, Cancer Treatment Centers), and Regional Analysis, 2023-2030
US$ 3,218.00
Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimer...
May 2023
200 pages
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
US$ 3,218.00
Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1....
May 2023
200 pages
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
US$ 3,218.00
Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. G...
May 2023
200 pages
Global Soft Tissue Sarcoma Market Size study & Forecast, by Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy), By Route of Administration (Oral, Parenteral, Others), By End-users (Hospitals, Homecare, Speciality Centres, Others), and Regional Analysis, 2023-2030
US$ 3,218.00
Global Soft Tissue Sarcoma Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Soft tiss...
May 2023
200 pages
Prebiotics Market by Ingredient (Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides, Mannan-oligosaccharides), Application (Food & Beverages {Dairy Products, Beverages, Infant Food Products}, Dietary Supplements), and Geography—Forecast to 2029
US$ 4,175.00
Prebiotics Market by Ingredient (Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides, Mannan-oligosaccharides), Application (Food & Beverages {Dairy Products, Beverages, Infant Food Products}, D...
May 2023
172 pages
